Valeritas Holdings, Inc. (NASDAQ:VLRX) is set to post its quarterly earnings results on Tuesday, August 8th. Analysts expect Valeritas Holdings to post earnings of ($1.87) per share for the quarter.

Valeritas Holdings (NASDAQ:VLRX) last released its quarterly earnings data on Friday, May 12th. The company reported ($6.92) EPS for the quarter, missing the Zacks’ consensus estimate of ($2.72) by $4.20. The business had revenue of $4.61 million for the quarter, compared to analysts’ expectations of $4.64 million. On average, analysts expect Valeritas Holdings to post $-8.23 EPS for the current fiscal year and $-4.93 EPS for the next fiscal year.

Valeritas Holdings, Inc. (NASDAQ:VLRX) opened at 5.35 on Monday. Valeritas Holdings, Inc. has a 52-week low of $4.51 and a 52-week high of $50.00. The firm’s 50-day moving average is $5.89 and its 200-day moving average is $13.58. The company’s market capitalization is $36.60 million.

In other Valeritas Holdings news, insider John Edward Timberlake bought 5,000 shares of the firm’s stock in a transaction dated Wednesday, May 17th. The stock was purchased at an average cost of $5.14 per share, with a total value of $25,700.00. Following the transaction, the insider now directly owns 23,037 shares in the company, valued at approximately $118,410.18. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last ninety days, insiders have bought 11,500 shares of company stock valued at $57,615. Insiders own 1.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at

VLRX has been the subject of several research analyst reports. ValuEngine lowered Valeritas Holdings from a “sell” rating to a “strong sell” rating in a research report on Thursday, May 11th. Cowen and Company initiated coverage on Valeritas Holdings in a research report on Monday, April 17th. They set an “outperform” rating for the company. Wedbush initiated coverage on Valeritas Holdings in a research report on Monday, July 10th. They set an “outperform” rating and a $12.00 target price for the company. Finally, B. Riley reaffirmed a “buy” rating and set a $10.00 target price on shares of Valeritas Holdings in a research report on Friday, May 12th.

Valeritas Holdings Company Profile

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Receive News & Stock Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related stocks with our FREE daily email newsletter.